E3 Ubiquitin Protein Ligase XIAP Market 2021 Analysis May Set New Growth Story, Forecast to 2027
The global E3 ubiquitin protein ligase XIAP market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Ubiquitin ligase is also called as E3 ubiquitin ligase. It is a protein that staffs an E2 ubiquitin-conjugating enzyme that has been loaded with ubiquitin and recognizes a protein substrate while assisting or directly catalyzing the transfer of ubiquitin from the E2 to the protein substrate. The major factor for the growth of the market is the increasing prevalence of cancer across the globe.
To Request a Sample of our Report on E3 Ubiquitin
Protein Ligase XIAP Market:
https://www.omrglobal.com/request-sample/e3-ubiquitin-protein-ligase-xiap-market
According to the National Cancer
Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be
diagnosed in the US with a mortality rate of 606,520 people in 2020. In men,
prostate, lung, and colorectal cancers will account for an estimated 43% of all
cancers diagnosed while for women, the three most common cancers are breast,
lung, and colorectal which will account for an estimated 50% of all new cancer
diagnoses in women in 2020. Furthermore, there were 18.1 million new cases and
9.5 million cancer-related mortalities globally in 2018 which is anticipated to
rise to 29.5 million and the number of cancer-related mortalities to 16.4
million by 2040. Hence, the rising prevalence of cancer is driving the growth
of the market as E3 ubiquitin protein ligase XIAP plays a crucial role in
protein function and regulation.
Some major key players in the
market include Novartis International AG, Bristol-Myers Squibb Company, and
Takeda Pharmaceutical Company Ltd., among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. In addition, funding opportunity has been witnessed,
which in turn, is expected to drive the market growth during the forecast
period. For instance, in June 2021, Stablix Therapeutics announced a $63
million Series A financing which was led by founding investor Versant Ventures
with NEA, Cormorant, Euclidean Capital and Alexandria Real Estate Equities.
Stablix is a biotechnology company that pioneers in the field of Targeted
Protein Stabilization (TPS).
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Novartis International AG, Bristol-Myers Squibb Company, and Takeda
Pharmaceutical Company Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of E3 Ubiquitin Protein Ligase XIAP Market is
Available @ https://www.omrglobal.com/industry-reports/e3-ubiquitin-protein-ligase-xiap-market
Global E3 Ubiquitin Protein Ligase XIAP Market Report by
Segment
By Type
• ASTX-660
• FL-118
• AD-O53.2
• LCL-161
• SM-1200
• Others
By Application
• Solid Tumor
• Fallopian Tube Cancer
• Lung Cancer
• Peritoneal Cancer
• Others
Global E3 Ubiquitin Protein Ligase XIAP Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment